Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Core Points - Rapid Dose Therapeutics Corp. plans to issue common shares to satisfy accrued interest on secured convertible notes by October 15, 2025 [1][4] - The financing involved units priced at $1.00 each, consisting of notes and warrants, totaling $3,134,445 in notes and 15,672,225 warrants issued in 2023 [2] - The notes have a maturity date of November 30, 2025, with a 12.0% annual interest rate, payable quarterly in common shares [3] Financial Details - The company will issue 592,533 common shares at a deemed price of $0.16 per share to cover $94,806.23 of accrued interest [4] - All common shares issued for interest payments will have a hold period of four months and one day from the issuance date [5] Company Overview - Rapid Dose Therapeutics is a Canadian biotechnology firm focused on innovative drug delivery, with its flagship product QuickStrip™, an orally dissolvable film for rapid delivery of various active ingredients [6]